252 related articles for article (PubMed ID: 37773823)
21. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
[TBL] [Abstract][Full Text] [Related]
22. Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study.
He JY; Zhang X; Wang K; Lv WQ
J Nutr; 2022 May; 152(5):1283-1290. PubMed ID: 35349717
[TBL] [Abstract][Full Text] [Related]
23. Association of genetically determined chronotype with circulating testosterone: a Mendelian randomization study.
Ichikawa T; Kobayashi T; Hachiya T; Ikehata Y; Isotani S; Ide H; Horie S
Front Endocrinol (Lausanne); 2024; 15():1264410. PubMed ID: 38737549
[TBL] [Abstract][Full Text] [Related]
24. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
[TBL] [Abstract][Full Text] [Related]
25. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
Tan Z; Hong J; Sun A; Ding M; Shen J
Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
[TBL] [Abstract][Full Text] [Related]
26. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
Huang W; Xiao J; Ji J; Chen L
Elife; 2021 Dec; 10():. PubMed ID: 34866576
[TBL] [Abstract][Full Text] [Related]
27. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
Liang Z; Zhao L; Lou Y; Liu S
QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
[TBL] [Abstract][Full Text] [Related]
28. Low LDL cholesterol,
Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
[No Abstract] [Full Text] [Related]
29. Genetically predicted high serum sex hormone-binding globulin levels are associated with lower ischemic stroke risk: A sex-stratified Mendelian randomization study.
Sun W; Wang Y; Li C; Yao X; Wu X; He A; Zhao B; Huang X; Song H
J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107686. PubMed ID: 38522757
[TBL] [Abstract][Full Text] [Related]
30. Putative causal inference for the relationship between obesity and sex hormones in males: a bidirectional Mendelian randomization study.
Wan B; Ma N; Zhou Z; Lv C
PeerJ; 2023; 11():e15760. PubMed ID: 37483981
[TBL] [Abstract][Full Text] [Related]
31. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
[TBL] [Abstract][Full Text] [Related]
32. Assessing the Casual Association between Sex Hormone Levels and Fracture Risk: A Two-Sample Mendelian Randomization Study.
Sun K; Ming Y; Xu J; Wu Y; Zeng Y; Wu L; Li M; Shen B
Orthop Surg; 2023 Dec; 15(12):3065-3074. PubMed ID: 37771125
[TBL] [Abstract][Full Text] [Related]
33. Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization Study.
Zhao SS; Yiu ZZN; Barton A; Bowes J
JAMA Dermatol; 2023 Mar; 159(3):275-280. PubMed ID: 36696131
[TBL] [Abstract][Full Text] [Related]
34. Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a Mendelian randomization analysis.
Chen H; Zhou X; Hu J; Li S; Wang Z; Zhu T; Cheng H; Zhang G
Lipids Health Dis; 2023 Dec; 22(1):220. PubMed ID: 38082436
[TBL] [Abstract][Full Text] [Related]
35. Potential association of genetically predicted lipid and lipid-modifying drugs with rheumatoid arthritis: A Mendelian randomization study.
Huang Z; Cui T; Yao J; Wu Y; Zhu J; Yang X; Cui L; Zhou H
PLoS One; 2024; 19(2):e0298629. PubMed ID: 38416767
[TBL] [Abstract][Full Text] [Related]
36. Investigating genetically mimicked effects of statins via HMGCR inhibition on immune-related diseases in men and women using Mendelian randomization.
Yang G; Schooling CM
Sci Rep; 2021 Dec; 11(1):23416. PubMed ID: 34862478
[TBL] [Abstract][Full Text] [Related]
37. Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function.
Rosoff DB; Bell AS; Jung J; Wagner J; Mavromatis LA; Lohoff FW
J Am Coll Cardiol; 2022 Aug; 80(7):653-662. PubMed ID: 35953131
[TBL] [Abstract][Full Text] [Related]
38. Genetic insights into repurposing statins for hyperthyroidism prevention: a drug-target Mendelian randomization study.
Huang A; Wu X; Lin J; Wei C; Xu W
Front Endocrinol (Lausanne); 2024; 15():1331031. PubMed ID: 38425755
[TBL] [Abstract][Full Text] [Related]
39. Genetic association of lipid-lowering drug target genes with erectile dysfunction and male reproductive health.
Su Q; Wang R; Luo Y; Tang Q; Wang K
Front Endocrinol (Lausanne); 2024; 15():1362499. PubMed ID: 38390206
[TBL] [Abstract][Full Text] [Related]
40. Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study.
Miao L; Miao T; Zhang Y; Hao J
BMC Cancer; 2024 May; 24(1):602. PubMed ID: 38760735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
